Article
Essential role of PR-domain protein MDS1-EVI1 in MLL-AF9 leukemia.
Blood - 17 Oct 2013
Zhang Yi, Owens Kristina, Hatem Layla, Glass Carolyn H, Karuppaiah Kannan, Camargo Fernando, Perkins Archibald S
Abstract excerpt
A subgroup of leukemogenic mixed-lineage leukemia (MLL) fusion proteins (MFPs) including MLL-AF9 activates the Mecom locus and exhibits extremely poor clinical prognosis. Mecom encodes EVI1 and MDS1-EVI1 (ME) proteins via alternative transcription start sites; these differ by the presence of a PR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
